\documentclass[dvips,10pt]{article}
\usepackage{graphicx}
\setlength{\oddsidemargin}{-0.3in}
\setlength{\textwidth}{7.0in}
\setlength{\topmargin}{-0.70in}
\setlength{\textheight}{9.5in}
\pagestyle{myheadings}
\markright{ {\rm {
GLND DSMB Report - Recruitment, Baseline, and Follow-up  OPEN SESSION
 \hspace{2em}
Tue Sep 15 14:15:44 EDT 2009
\hfill
\hspace{3em}
}}}
\headsep=0.2in
\begin{document}
\vspace*{1in}
\begin{center}
{\Huge{CONFIDENTIAL}}
\end{center}
\vspace*{0.5in}
\begin{center}
{\Huge{Efficacy and Mechanisms of GLN Dipeptide in the SICU GLND Trial}}
\end{center}
\vspace*{0.5in}
\begin{center}
{\Huge{Data Safety Monitoring Board Report}}
\end{center}
\vspace*{0.25in}
\begin{center}
{\Huge{
Recruitment, Baseline, and Follow-up  OPEN SESSION
}}
\end{center}
\vspace*{1in}
\begin{center}
{\Huge{GLND DSMB Meeting}}
\end{center}
\begin{center}
{\Huge{
 Tues, March 31, 2009
}}
\end{center}
\begin{center}
{\Huge{1-5 pm EDT}}
\end{center}
\vspace*{1in}
\begin{center}
\noindent
{\Large{Includes patients enrolled and follow-up data received as of March 03, 2009}}
\end{center}
\vspace*{0.5in}
\begin{center}
{\Large{Report prepared  Tue Sep 15 14:15:44 EDT 2009 }}
\end{center}
\clearpage
\vspace*{1in}
\begin{center}
{\Huge{Table of Contents}}
\end{center}
\listoftables
\listoffigures
\clearpage
\clearpage
\begin{table}[t]
\caption
{ GLND Retention. }
\begin{center}
\begin{tabular}{ @{}l@{}
@{}l@{}@{}p{1.5em}@{}@{}c@{}@{}p{1.5em}@{}@{}c@{}@{}p{1.5em}@{}@{}c@{}@{}p{1.5em}@{}@{}c@{}
}
\hline

& \parbox{6em}{\begin{center}Form\end{center}} && \parbox{6em}{\begin{center}Emory Blood Obtained? Total(\%)\end{center}} && \parbox{6em}{\begin{center}Colorado Blood Obtained? Total(\%)\end{center}} && \parbox{6em}{\begin{center}Vanderbilt Blood Obtained? Total(\%)\end{center}} && \parbox{6em}{\begin{center}Miriam Blood Obtained? Total(\%)\end{center}} \\

\hline

\\
& Baseline Blood Coll. && 39 (97.5\%) && 21 (100\%) && 23 (100\%) && 9 (100\%) \\
& Day 3 Blood Coll. && 34 (85.0\%) && 21 (100\%) && 22 (95.7\%) && 9 (100\%) \\
& Day 7 Blood Coll. && 34 (91.9\%) && 18 (85.7\%) && 19 (82.6\%) && 9 (100\%) \\
& Day 14 Blood Coll. && 26 (70.3\%) && 11 (57.9\%) && 16 (76.2\%) && 9 (100\%) \\
& Day 21 Blood Coll. && 20 (57.1\%) && 9 (47.4\%) && 7 (36.8\%) && 7 (77.8\%) \\
& Day 28 Blood Coll. && 15 (46.9\%) && 6 (33.3\%) && 8 (44.4\%) && 5 (62.5\%) \\
\\
\hline \\

\end{tabular}

\end{center}
 \end{table}
\begin{table}[t]
\caption
{ SAE. }
\begin{center}
\begin{tabular}{ @{}l@{}
@{}l@{}@{}p{1.5em}@{}@{}c@{}@{}p{1.5em}@{}@{}c@{}
}
\hline

& \parbox{6em}{\begin{center}Adverse Event\end{center}} && \parbox{6em}{\begin{center}Total n=98\end{center}} && \parbox{6em}{\begin{center}Days From Enrollment  (median)\end{center}} \\

\hline

\\
& Death && 20( 20) 20.6\% && 18 \\
& Anaphylactic reaction && 0(  0)  0.0\% &&  \\
& Seizure && 1(  1)  1.0\% && 84 \\
& Cardiopulmonary arrest && 3(  3)  3.1\% && 14 \\
& Re-hospitalization w/in 30 days && 19( 17) 17.5\% && 31 \\
& Re-operation w/in 30 days && 32( 17) 17.5\% && 10 \\
& New cancer diagnosis && 0(  0)  0.0\% &&  \\
& Congenital anomaly/disorder && 0(  0)  0.0\% &&  \\
& Any SAE && 75( 47) 48.5\% &&  \\
\\
\hline \\

\end{tabular}


\parbox{ 5in }{ \# AEs (\# Pat) \% Pat \newline Per protocol, an SAE form is completed only for events that occur within 30
  days of study drug discontinuation.  An additional 10 patients have died within
  the 6 month follow-up period (see next page). } \\
 \vspace{1em}\end{center}
 \end{table}
\clearpage

\begin{figure}
\resizebox{6.5in}{!}{\rotatebox{0}{\includegraphics{//glnd//sas//reporting//nutsum.ps}}}
\caption{Daily Nutritional kcal Summaries}
\end{figure}
\clearpage
\end{document}
